AXiR Engine® tells you the risk of future disease in your body.
Until today we’ ve been ignoring small signal in our body if we feel that the pain is a split second or very short period.
In Japan we see the number of deaths by cancer like 370,000 people and the number is similar in the past 6 years.
Maybe the fatalities number will be similar in 2018 and this causes the next guess like that the next year candidate
370,000 are waiting for cancer death order because of invisible reason today.
The total number of individuals affected by cancer in Japan is about 1,000,000 and the number means 37% people
might be going to die. Medical doctor is focusing on patients who are clearly suffering from actual diseases like cancer.
AXiON Research Inc., we assume the invisible path to reach those diseases and some reason with scientific background
must be there to meet the numbers repeated every year. In The “Compass to Healthy Life”
Research Complex Program organized by RIKEN and supported by JST, in July 2018, AXiON Research Inc. shows
the performance of Replica Generator III to increase data of healthcare on 415 people data up to 4,150.
It’ s really good result and succeeded in increase of 4 initial disease risk categories up to 7 ones after the data generation
with keeping the original statistical feature and accuracy. It also keeps the probability density, the dispersion and the
distribution of the original data increasing the number per different age and gender. It contributes the future analysis
of 10,000 people data and analyzes health indices and invisible disease risk prediction for pre-disease state.AXiON Research Inc. is introducing new methodology to identify
the health indices / position in pre-disease state group
and how quickly getting worse by checking autonomic nerves
activities or up / down parameters related to individual immunity.
Heatmap of health condition/disease risk level helps the
identification of the risk and vector-map of disease
risk level works how much, how quickly getting worse
or shifting the next stage of future diseases.
The challenge started a few years ago and various technologies /
research results are accelerating the analysis process and its accuracy.
Today medical service is often using X-ray, MRI, CT or PET and
it can identify the disease itself at very high rate. However,
it does usually work as an answer like you have no problem at all, at least today.
Some of pre-disease state people might be waiting for new technology
to make some advice or estimation of future disease risk at very early stage.
We introduce AXiR Engine® for how much healthy you are or we are.
We’ re going to the next pre-service stage with strategic partners to
run the service into the real world and commercial service.We’ re seeking the next fundraising
Series A in 2019. Series A 1st will be
between Jan. and Apr. 2019.
Series A 2nd will be between June and
Oct. 2019. Welcome, Early Entries.